IGC Pharma enters agreement to sell shares at $0.27 per share
IGC Pharma entered into a Stock Purchase Agreement to issue shares to a Purchaser for $0.27 per share. The transaction is scheduled to close on June 30, 2026, and will be settled through the cancellation of existing debt.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
GET FREE KEY — 10,000 calls/day